Life Care Specialists (LCS) With a Focus on Patient Pain Management and Prevention of Substance Misuse
2 other identifiers
interventional
333
1 country
1
Brief Summary
The overall hypothesis of this randomized-controlled trial is that the introduction of a Life Care Specialist (LCS) as a novel member of the clinical care team will help reduce opioid utilization, decrease pain scores, and improve patient understanding of their addiction risk in the aftermath of orthopaedic trauma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2019
CompletedFirst Posted
Study publicly available on registry
November 6, 2019
CompletedStudy Start
First participant enrolled
February 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2022
CompletedResults Posted
Study results publicly available
November 21, 2024
CompletedNovember 21, 2024
November 1, 2024
2.8 years
November 2, 2019
June 22, 2023
November 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Numeric Rating Scale Average Pain Score
For participants in the single-arm pilot study and in the dual-arm, clinical-trial portion of the study, daily pain within the last 24 hours was assessed using a 10-point Likert scale where 1 = no pain and 10 = severe pain. After Week 2, pain was assessed only during the follow-up visits.
Day 1 (during inpatient hospitalization), Week 2, Week 6, Month 3
Number of Participants With Improvement in the Numeric Rating Scale (NRS) Average Pain Score
The number of participants in the dual-arm, clinical-trial portion of the study reporting a decrease in the NRS average pain score at 3 months follow-up compared to the baseline visit.
Month 3
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form Score
For participants in the dual-arm, clinical trial portion of the study, severity of insomnia, sleep disruption, and sleep quality over the past seven days is assessed with the 4-item PROMIS Sleep Disturbance - Short Form. Responses are given on a 5-point Likert scale where 1 is equivalent to best possible and 5 is equivalent to worst possible. Raw scores are converted to t-scores ranging from 0 to 100, with a mean of 50 and standard deviation of 10. Scores below 50 indicate better sleep than the average person.
Day 1 (during inpatient hospitalization), Week 2, Week 6, Month 3
PROMIS Pain Interference - Short Form Score
For participants in the dual-arm, clinical trial portion of the study, self-reported pain interference with activities is assessed with the PROMIS Pain Interference - Short Form. Responses to the 4 items are given on a 5-point Likert scale from 1 (no interference) to 5 (much interference). Raw scores are converted to t-scores ranging from 0 to 100, with a mean of 50 and standard deviation of 10. Scores above 50 indicate worse pain interference than the average person.
Day 1 (during inpatient hospitalization), Week 2, Week 6, Month 3
PROMIS Physical Function - Short Form Score
For participants in the dual-arm, clinical trial portion of the study, self-reported capability to conduct physical activity is assessed with the PROMIS Physical Function - Short Form. Responses to the 4 items are given on a 5-point Likert scale where 1 = unable to do and 5 = without any difficulty. Raw scores are converted to t-scores ranging from 0 to 100, with a mean of 50 and a standard deviation of 10. Scores above 50 indicate better physical function than the average person.
Day 1 (during inpatient hospitalization), Week 2, Week 6, Month 3
Secondary Outcomes (8)
Opioid Utilization
Day 1 (during inpatient hospitalization)
Opioid Literacy Tool (OLT) Score
Day 1 (during inpatient hospitalization), Month 3
Total Sleep Time
Up to 72 hours (during inpatient hospitalization)
Percentage of Sleep Fragmentation
Day 1 (during inpatient hospitalization)
Patient Satisfaction Survey
Week 2
- +3 more secondary outcomes
Study Arms (3)
Life Care Specialist (LCS) Intervention
EXPERIMENTALIn addition to receiving current standard-of-care for pain management in the aftermath of trauma, participants will have the full communication of opioid risk - via the validated Opioid Risk Tool (ORT) and a detailed substance abuse and mental health screening. As part of the daily LCS intervention, the inpatients will engage in behavioral pain management, opioid education and harm-reduction strategies (naloxone education), while also being screened for eligibility for respective referrals for complex needs, such as mental health and substance use disorders. Upon discharge, each participant will be educated by the LCS on future available modes of contact (telephone, email, video-call, follow up- visits at 2-, 6- and 12-weeks).
Standard of Care with Clinical Coordination
ACTIVE COMPARATORParticipants will receive the current standard-of-care for pain management in the aftermath of trauma, including a standardized prescription protocol, and hospital-system approved discharge instructions which provide written instruction on how to taper opioid use and links to written/online resources for opioid misuse, overdose prevention, and State-approved disposal options.
Pilot Study of Pain Management Strategies
OTHEROrthopedic trauma patients will work with a Life Care Specialist (LCS) and will receive personalized pain management strategies to avoid potential opioid misuse. Participants will be followed for one-year post-operation. An official pain management protocol will be developed during the pilot portion of this study
Interventions
The Life Care Specialist (LCS) uses a two-arm approach to education by initially assessing participants general understanding of opioids upon which targeted education is tailored and applied and secondly, building a longitudinal relationship with each patient to increase the saliency of administered opioid education during postoperative follow-up. Information includes proper disposal, common symptoms of opioid use, signs of dependence and overdose and use of naloxone. Information is disseminated orally with adjunct physical resource guides including visual representations and literature.
The Life Care Specialist (LCS) can help arrange a referral for the participant, should a medical or social issue be identified during LCS intervention, including mental health services, addiction medicine services, housing insecurity referrals, food insecurity referrals, and amputee support. When giving referrals, the LCS works closely with physicians and nurses to make sure that the participant is a good fit for the referral program.
Orthopedic trauma patients will work with a Life Care Specialist (LCS) and will receive personalized pain management strategies to avoid potential opioid misuse.
Eligibility Criteria
You may qualify if:
- Orthopaedic trauma patients with planned surgical procedure
- Informed consent obtained
You may not qualify if:
- Enrolled in a study that does not permit co-enrollment
- Unlikely to comply with the follow-up schedule
- Unable to converse, read or write English or Spanish at elementary school level
- Orthopaedic trauma patients with an isolated injury requiring surgery
- Informed consent obtained
- Functioning cellphone
- Enrolled in a study that does not permit co-enrollment
- Unlikely to comply with the follow-up schedule
- Unable to converse, read or write English or Spanish at elementary school level
- Unlikely to complete surveys at home, access to phone
- Unlikely to respond to opioid utilization text messaging (SMS)
- Incarcerated
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Christopher Wolf Crusade (CWC)collaborator
- Centers for Disease Control and Preventioncollaborator
Study Sites (1)
Grady Health System
Atlanta, Georgia, 30322, United States
Related Publications (3)
Giordano NA, Seilern Und Aspang J, Baker J, Rice CW, Barrell B, Kirk L, Ortega E, Wallace M, Steck A, Schenker ML. The effect of a Life Care Specialist on pain management and opioid-related outcomes among patients with orthopedic trauma: study protocol for a randomized controlled trial. Trials. 2021 Nov 27;22(1):858. doi: 10.1186/s13063-021-05841-1.
PMID: 34838101BACKGROUNDGiordano NA, Seilern Und Aspang J, Baker J, Medline A, Rice CW, Barrell B, Kirk L, Ortega E, Wallace M, Steck A, Schenker ML. Integration of Life Care Specialists Into Orthopaedic Trauma Care to Improve Postoperative Outcomes: A Pilot Study. Pain Manag Nurs. 2022 Oct;23(5):608-615. doi: 10.1016/j.pmn.2022.03.010. Epub 2022 Apr 25.
PMID: 35477669RESULTGiordano NA, Und Aspang JS, Baker J, Holder C, Cantu N, Checo G, Rice CW, Barrell B, Wallace M, Steck AR, Schenker ML. Can Patient-centered Education and Pain Management Delivered by Coaches Improve Pain Outcomes After Orthopaedic Trauma? A Randomized Trial. Clin Orthop Relat Res. 2024 Oct 1;482(10):1858-1869. doi: 10.1097/CORR.0000000000003121. Epub 2024 May 15.
PMID: 38843502RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The nature of this preliminary research began as a single-arm pilot study but due to the coronavirus disease 2019 (COVID-19) pandemic, the pilot was suspended. A two-arm clinical trial was commenced due to time constraints at a time when non-essential personnel, including research staff, were permitted to safely return to the fast-paced clinical environment once infection control measures were established. Many of the outcome measures for the clinical trial did not apply to the pilot study.
Results Point of Contact
- Title
- Mara L. Schenker
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Mara Schenker, MD
Emory University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 2, 2019
First Posted
November 6, 2019
Study Start
February 21, 2020
Primary Completion
December 19, 2022
Study Completion
December 19, 2022
Last Updated
November 21, 2024
Results First Posted
November 21, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Individual participant data will be available for sharing following publication of the findings from this study until 5 years after publication.
- Access Criteria
- Researchers interested in accessing data should provide a description of the proposed project to Dr. Schenker at mara.schenker@emory.edu.
Deidentified, individual participant data will be made available for sharing upon request from other researchers.